Characterization of insulin signaling in rat retina in vivo and ex vivo

American Journal of Physiology - Endocrinology and Metabolism

Volumn 285, Issue 4 48-4, 2003, Pages

  Reiter, Chad E N ^a   Sandirasegarane, Lakshman ^a   Wolpert, Ellen B ^a   Klinger, Marianne ^a   Simpson, Ian A ^a   Barber, Alistair J ^a   Antonetti, David A ^a   Kester, Mark ^a   Gardner, Thomas W ^a,b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Akt; Diabetic retinopathy; Insulin receptor

Indexed keywords

INSULIN; INSULIN RECEPTOR; PHOSPHOTRANSFERASE; PHOSPHOTYROSINE; PROTEIN KINASE B; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HORMONE ACTION; IMMUNOBLOTTING; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RETINA; RETINA CELL; SIGNAL TRANSDUCTION;

EID: 0141727761     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00507.2002     Document Type: Article

References (73)

1. Abbott MA, Wells DG, and Fallon JR. The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. J Neurosci 19: 7300-7308, 1999.
2. Altomare DA, Lyons GE, Mitsuuchi Y, Cheng JQ, and Testa JR. Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. Oncogene 16: 2407-2411, 1998.
3. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B III, Johnson RS, and Kahn CR. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372: 186-190, 1994.
4. Avruch J. Insulin signal transduction through protein kinase cascades. Mol Cell Biochem 182: 31-48, 1998.
5. Banks WA and Kastin AJ. Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides 19: 883-889, 1998.
6. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, and Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102: 783-791, 1998.
7. Barber AJ, Nakamura M, Wolpert EB, Reiter CEN, Seigel GM, Antonetti DA, and Gardner TW. Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3. J Biol Chem 276: 32814-32821, 2001.
8. Baskin DG, Sipols AJ, Schwartz MW, and White MF. Immunocytochemical detection of insulin receptor substrate-1 (IRS-1) in rat brain: colocalization with phosphotyrosine. Regul Pept 48: 257-266, 1993.
9. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, and Greenberg ME. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868, 1999.
10. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, and Kahn CR. Role of brain insulin receptor in control of body weight and reproduction. Science 289: 2122-2125, 2000.
11. Budd GC, Pansky B, and Glatzer L. Preproinsulin mRNA in the rat eye. Invest Ophthalmol Vis Sci 34: 463-469, 1993.
12. Cai J, Nelson KC, Wu M, Sternberg P Jr, and Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res 19: 205-221, 2000.
13. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, and Reed JC. Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321, 1998.
14. Cusato K, Bosco A, Linden R, and Reese BE. Cell death in the inner nuclear layer of the retina is modulated by BDNF. Brain Res Dev Brain Res 139: 325-330, 2002.
15. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, and Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241, 1997.
16. Diaz B, Serna J, De Pablo F, and de la Rosa EJ. In vivo regulation of cell death by embryonic (pro)insulin and the insulin receptor during early retinal neurogenesis. Development 127: 1641-1649, 2000.
17. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, and Greenberg ME. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665, 1997.
18. Folli F, Bonfanti L, Renard E, Kahn CR, and Merighi A. Insulin receptor substrate-1 (IRS-1) distribution in the rat central nervous system. J Neurosci 14: 6412-6422, 1994.
19. Folli F, Saad MJ, Backer JM, and Kahn CR. Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J Biol Chem 267: 22171-22177, 1992.
20. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A, and Vigneri R. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19: 3278-3288, 1999.
21. Gosbell AD, Favilla I, Baxter KM, and Jablonski P. Insulin receptor and insulin receptor substrate-I in rat retinae. Clin Experiment Ophthalmol 28: 212-215, 2000.
22. Gosbell AD, Favilla I, and Jablonski P. The location of insulin receptors in bovine retina and isolated retinal cells. Clin Exp Ophthalmol 30: 124-130, 2002.
23. Havrankova J, Roth J, and Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272: 827-829, 1978.
24. Hermann C, Assmus B, Urbich C, Zeiher AM, and Dimmeler S. Insulin-mediated stimulation of protein kinase Akt: a potent survival signaling cascade for endothelial cells. Arterioscler Thromb Vasc Biol 20: 402-409, 2000.
25. Hetman M, Cavanaugh JE, Kimelman D, and Xia Z. Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J Neurosci 20: 2567-2574, 2000.
26. James CR and Cotlier E. Fate of insulin in the retina: an autoradiographic study. Br J Ophthalmol 67: 80-88, 1983.
27. Jialal I, Crettaz M, Hachiya HL, Kahn CR, Moses AC, Buzney SM, and King GL. Characterization of the receptors for insulin and the insulin-like growth factors on micro- and macrovascular tissues. Endocrinology 117: 1222-1229, 1985.
28. Jones PF, Jakubowicz T, and Hemmings BA. Molecular cloning of a second form of rac protein kinase. Cell Regul 2: 1001-1009, 1991.
29. Kermer P, Klocker N, Labes M, and Bahr M. Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 In vivo. J Neurosci 20: 2-8, 2000.
30. Kim AH, Khursigara G, Sun X, Franke TF, and Chao MV. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 21: 893-901, 2001.
31. Koehler-Stec EM, Simpson IA, Vannucci SJ, Landschulz KT, and Landscbulz WH. Monocarboxylate transporter expression in mouse brain. Am J Physiol Endocrinol Metab 275: E516-E524, 1998.
32. Konishi H, Kuroda S, Tanaka M, Matsuzaki H, Ono Y, Kameyama K, Haga T, and Kikkawa U. Molecular cloning and characterization of a new member of the RAC protein kinase family: association of the pleckstrin homology domain of three types of RAC protein kinase with protein kinase C subspecies and beta gamma subunits of G proteins. Biochem Biophys Res Commun 216: 526-534, 1995.
33. Lieth E, LaNoue KF, Antonetti DA, and Ratz M. Diabetes reduces glutamate oxidation and glutamine synthesis in the retina. The Penn State Retina Research Group. Exp Eye Res 70: 723-730, 2000.
34. Lieth E, LaNoue KF, Berkich DA, Xu B, Ratz M, Taylor C, and Hutson SM. Nitrogen shuttling between neurons and glial cells during glutamate synthesis. J Neurochem 76: 1712-1723, 2001.
35. Louvi A, Accili D, and Efstratiadis A. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 189: 33-48, 1997.
36. Lund PK, Moats-Staats BM, Hynes MA, Simmons JG, Jansen M, D'Ercole AJ, and Van Wyk JJ. Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J Biol Chem 261: 14539-14544, 1986.
37. Marte BM and Downward J. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22: 355-358, 1997.
38. Meyer-Schwickerath R, Pfeiffer A, Blum WF, Freyberger H, Klein M, Losche C, Rollmann R, and Schatz H. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J Clin Invest 92: 2620-2625, 1993.
39. Mizutani M, Kern TS, and Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97: 2883-2890, 1996.
40. Mo X, Yokoyama A, Oshitari T, Negishi H, Dezawa M, Mizota A, and Adachi-Usami E. Rescue of axotomized retinal ganglion cells by BDNF gene electroporation in adult rats. Invest Ophthalmol Vis Sci 43: 2401-2405, 2002.
41. Moss AM, Unger JW, Moxley RT, and Livingston JN. Location of phosphotyrosine-containing proteins by immunocytochemistry in the rat forebrain corresponds to the distribution of the insulin receptor. Proc Natl Acad Sci USA 87: 4453-4457, 1990.
42. Nakamura M, Barber AJ, Antonetti DA, LaNoue KF, Robinson KA, Buse MG, and Gardner TW. Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J Biol Chem 276: 43748-43755, 2001.
43. Nakatani K, Sakaue H, Thompson DA, Weigel RJ, and Roth RA. Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. Biochem Biophys Res Commun 257: 906-910, 1999.
44. Nystrom FH and Quon MJ. Insulin signalling: metabolic pathways and mechanisms for specificity. Cell Signal 11: 563-574, 1999.
45. Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, and Belfiore A. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 277: 39684-39695, 2002.
46. Pekarsky Y, Koval A, Hallas C, Bichi R, Tresini M, Malstrom S, Russo G, Tsichlis P, and Croce CM. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci USA 97: 3028-3033, 2000.
47. Peyssonnaux C, Provot S, Felder-Schmittbuhl MP, Calothy G, and Eychene A. Induction of postmitotic neuroretina cell proliferation by distinct Ras downstream signaling pathways. Mol Cell Biol 20: 7068-7079, 2000.
48. Pimentel B, Rodriguez-Borlado L, Hernandez C, and Carrera AC. A role for phosphoinositide 3-kinase in the control of cell division and survival during retinal development. Dev Biol 247: 295-306, 2002.
49. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, and Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 36: 774-786, 1995.
50. Rajala RV and Anderson RE. Interaction of the insulin receptor beta-subunit with phosphatidylinositol 3-kinase in bovine ROS. Invest Ophthalmol Vis Sci 42: 3110-3117, 2001.
51. Rajala RV, McClellan ME, Ash JD, and Anderson RE. In vivo regulation of phosphoinositide 3-kinase in retina through light-induced tyrosine phosphorylation of the insulin receptor beta-subunit. J Biol Chem 277: 43319-43326, 2002.
52. Rodrigues M, Waldbillig RJ, Rajagopalan S, Hackett J, LeRoith D, and Chader GJ. Retinal insulin receptors: localization using a polyclonal anti-insulin receptor antibody. Brain Res 443: 389-394, 1988.
53. Romashkova JA and Makarov SS. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 86-90, 1999.
54. Sandirasegarane L and Kester M. Enhanced stimulation of Akt-3/protein kinase B-gamma in human aortic smooth muscle cells. Biochem Biophys Res Commun 283: 158-163, 2001.
55. Seigel GM, Chiu L, and Paxhia A. Inhibition of neuroretinal cell death by insulin-like growth factor-1 and its analogs. Mol Vis 6: 157-163, 2000.
56. Seino S and Bell GI. Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun 159: 312-316, 1989.
57. Shires TK, Braddock KJ, and Pulido JS. Insulin in the vitreous of the normal and streptozotocin-induced diabetic rat. Peptides 13: 671-675, 1992.
58. Simon J, Rosebrough RW, McMurtry JP, Steele NC, Roth J, Adamo M, and LeRoith D. Fasting and refeeding alter the insulin receptor tyrosine kinase in chicken liver but fail to affect brain insulin receptors. J Biol Chem 261: 17081-17088, 1986.
59. Taha C and Klip A. The insulin signaling pathway. J Membr Biol 169: 1-12, 1999.
60. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Harikoshi H, Furata Y, Ikawa Y, Kasuga M, Yazaki Y, and Aizawa S. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372: 182-186, 1994.
61. Tobe K, Koshio O, Tashiro-Hashimoto Y, Takaku F, Akanuma Y, and Kasuga M. Immunological detection of phosphotyrosine-containing proteins in rat livers after insulin injection. Diabetes 39: 528-533, 1990.
62. Unger JW, Moss AM, and Livingston JN. Immunohistochemical localization of insulin receptors and phosphotyrosine in the brainstem of the adult rat. Neuroscience 42: 853-861, 1991.
63. Vannucci SJ, Maher F, and Simpson IA. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 21: 2-21, 1997.
64. Venters HD, Tang Q, Liu Q, VanHoy RW, Dantzer R, and Kelley KW. A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci USA 96: 9879-9884, 1999.
65. Waldbillig RJ, Fletcher RT, Chader GJ, Rajagopalan S, Rodrigues M, and LeRoith D. Retinal insulin receptors. 1. Structural heterogeneity and functional characterization. Exp Eye Res 45: 823-835, 1987.
66. Waldbillig RJ, Fletcher RT, Chader GJ, Rajagopalan S, Rodrigues M, and LeRoith D. Retinal insulin receptors. 2. Characterization and insulin-induced tyrosine kinase activity in bovine retinal rod outer segments. Exp Eye Res 45: 837-844, 1987.
67. White MF. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 283: E413-E422, 2002.
68. Williamson JR and Corkey BE. Assays of intermediates of the citric acid cycle and related compounds by fluorometric enzyme methods. In: Methods Enzymol, edited by Lowenstein J. New York: Academic, 1969, p. 434-513.
69. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, and White MF. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391: 900-904, 1998.
70. Yamada M, Ohnishi H, Sano S, Nakatani A, Ikeuchi T, and Hatanaka H. Insulin receptor substrate (IRS)-1 and IRS-2 are tyrosine-phosphorylated and associated with phosphatidylinositol 3-kinase in response to brain-derived neurotrophic factor in cultured cerebral cortical neurons. J Biol Chem 272: 30334-30339, 1997.
71. Yamaguchi A, Tamatani M, Matsuzaki H, Namikawa K, Kiyama H, Vitek MP, Mitsuda N, and Tohyama M. Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J Biol Chem 276: 5256-5264, 2001.
72. Yano S, Morioka M, Fukunaga K, Kawano T, Hara T, Kai Y, Hamada J, Miyamoto E, and Ushio Y. Activation of Akt/protein kinase B contributes to induction of ischemic tolerance in the CA1 subfield of gerbil hippocampus. J Cereb Blood Flow Metab 21: 351-360, 2001.
73. Zhou Q, Dolan PL, and Dohm GL. Dephosphorylation increases insulin-stimulated receptor kinase activity in skeletal muscle of obese Zucker rats. Mol Cell Biochem 194: 209-216, 1999.